{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:14:01Z","timestamp":1791090841691,"version":"4.1.0"},"reference-count":32,"publisher":"American Chemical Society (ACS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem. Res. Toxicol."],"published-print":{"date-parts":[[2003,3,1]]},"DOI":"10.1021\/tx0256127","type":"journal-article","created":{"date-parts":[[2003,3,17]],"date-time":"2003-03-17T15:27:05Z","timestamp":1047914825000},"page":"295-303","source":"Crossref","is-referenced-by-count":223,"title":["An Integrated Metabonomic Investigation of Acetaminophen Toxicity in the Mouse Using NMR Spectroscopy"],"prefix":"10.1021","volume":"16","author":[{"given":"Muireann","family":"Coen","sequence":"first","affiliation":[{"name":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, United Kingdom, Drug Metabolism and Pharmacokinetics, AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom, and Safety Assessment, AstraZeneca Pharmaceuticals, Wilmington, Delaware 19850"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Lenz","sequence":"additional","affiliation":[{"name":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, United Kingdom, Drug Metabolism and Pharmacokinetics, AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom, and Safety Assessment, AstraZeneca Pharmaceuticals, Wilmington, Delaware 19850"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy K.","family":"Nicholson","sequence":"additional","affiliation":[{"name":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, United Kingdom, Drug Metabolism and Pharmacokinetics, AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom, and Safety Assessment, AstraZeneca Pharmaceuticals, Wilmington, Delaware 19850"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, United Kingdom, Drug Metabolism and Pharmacokinetics, AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom, and Safety Assessment, AstraZeneca Pharmaceuticals, Wilmington, Delaware 19850"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Pognan","sequence":"additional","affiliation":[{"name":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, United Kingdom, Drug Metabolism and Pharmacokinetics, AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom, and Safety Assessment, AstraZeneca Pharmaceuticals, Wilmington, Delaware 19850"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lindon","sequence":"additional","affiliation":[{"name":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, United Kingdom, Drug Metabolism and Pharmacokinetics, AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom, and Safety Assessment, AstraZeneca Pharmaceuticals, Wilmington, Delaware 19850"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2003,1,23]]},"reference":[{"key":"tx0256127b00001\/tx0256127b00001_1","doi-asserted-by":"crossref","DOI":"10.1038\/nrd728","volume":"1","author":"Nicholson J. K.","year":"2002","journal-title":"Nat Rev. Drug Discovery"},{"key":"tx0256127b00002\/tx0256127b00002_1","doi-asserted-by":"crossref","unstructured":"Nicholson, J. K., Lindon, J. C., and Holmes, E. (1999) Metabonomics:\u2009 understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.Xenobiotica29, 1181\u22121189.","DOI":"10.1080\/004982599238047"},{"key":"tx0256127b00003\/tx0256127b00003_1","volume-title":"Metabonomics:\u2009 metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magn. Reson. 12, 289\u2212320","author":"Lindon J. C.","year":"2000"},{"key":"tx0256127b00004\/tx0256127b00004_1","volume-title":"High-resolution 1H and 1H-13C magic angle spinning NMR spectroscopy of rat liver. Magn. Reson. Med. 44, 201\u2212207","author":"Bollard M. E.","year":"2000"},{"key":"tx0256127b00005\/tx0256127b00005_1","volume-title":"High resolution 1H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2-bromoethanamine in intact renal and hepatic tissue. Magn. Reson. Med. 41, 1108\u22121118","author":"Garrod S.","year":"1999"},{"key":"tx0256127b00006\/tx0256127b00006_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0079-6565(00)00036-4","volume":"39","author":"Lindon J. C.","year":"2001","journal-title":"Prog. NMR Spectrosc."},{"key":"tx0256127b00007\/tx0256127b00007_1","volume-title":"Chemometric models for 303 toxicityclassification based on NMR spectra of biofluids. Chem. Res. Toxicol. 13, 471\u2212478","author":"Holmes E.","year":"2000"},{"key":"tx0256127b00008\/tx0256127b00008_1","volume-title":"Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol. 11, 260\u2212272","author":"Beckwith-Hall B. M.","year":"1998"},{"key":"tx0256127b00009\/tx0256127b00009_1","doi-asserted-by":"crossref","unstructured":"Millis, K., Mass, W. E., Cory, D., and Singer, S. (1997) Gradient high-resolution magic angle spinning NMR spectroscopy of human adipocyte tissue.Magn. Reson. Med.38, 399\u2212403.","DOI":"10.1002\/mrm.1910380307"},{"key":"tx0256127b00010\/tx0256127b00010_1","volume-title":"Gradient high-resolution, magic angle spinning 1H nuclear magnetic resonance spectroscopy of intact cells. Magn. Reson. Med. 39, 337\u2212344","author":"Weybright P.","year":"1998"},{"key":"tx0256127b00011\/tx0256127b00011_1","volume-title":"High-resolution magic angle spinning 1H NMR analysis of intact prostatic hyperplastic and tumour tissues. Anal. Commun. 35, 113\u2212115","author":"Tomlins A.","year":"1998"},{"key":"tx0256127b00012\/tx0256127b00012_1","volume-title":"Proc. Natl. Acad. Sci. U.S.A. 94","author":"Cheng L. L.","year":"1997"},{"key":"tx0256127b00013\/tx0256127b00013_1","doi-asserted-by":"crossref","unstructured":"Waters, N. J., Holmes, E., Williams, A., Waterfield, C., Farrant, R. D., Nicholson, J. K. (2001) NMR and pattern recognition studies on the time-related metabolic effects of \u03b1-naphthylisothiocyanate on liver, urine and plasma in the rat:\u2009 an integrative metabonomic approach.Chem. Res. Toxicol.14, 1401\u22121412.","DOI":"10.1021\/tx010067f"},{"key":"tx0256127b00014\/tx0256127b00014_1","volume":"26","author":"Boyd E. M.","year":"1966","journal-title":"Br. J. Pharmacol."},{"key":"tx0256127b00015\/tx0256127b00015_1","volume":"5512","author":"Davidson D. G.","year":"1966","journal-title":"Br. Med. J."},{"key":"tx0256127b00016\/tx0256127b00016_1","volume":"178","author":"Davis M.","year":"1976","journal-title":"Q. J. Med."},{"key":"tx0256127b00017\/tx0256127b00017_1","volume-title":"Acute renal failure associated with acetaminophen ingestion:\u2009 report of a case and review of the literature. Clin. Nephrol. 14, 201\u2212205","author":"Kleinman J. G.","year":"1980"},{"key":"tx0256127b00018\/tx0256127b00018_1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0041-008X(78)90139-4","volume":"46","author":"McMurtry R. J.","year":"1978","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"tx0256127b00019\/tx0256127b00019_1","volume":"64","author":"Shaka A. J.","year":"1985","journal-title":"J. Magn. Reson."},{"key":"tx0256127b00020\/tx0256127b00020_1","volume":"101","author":"Muller L.","year":"1979","journal-title":"J. Am. Chem. Soc."},{"key":"tx0256127b00021\/tx0256127b00021_1","volume":"65","author":"Bax A.","year":"1985","journal-title":"J. Magn. Reson."},{"key":"tx0256127b00022\/tx0256127b00022_1","volume-title":"Phospholipid identification and quantification of membrane vesicle subfractions by 31P-1H two-dimensional nuclear magnetic resonance. Lipids 35, 1289\u22121297","author":"Larijani B.","year":"2000"},{"key":"tx0256127b00023\/tx0256127b00023_1","volume-title":"Orthogonal signal correction of near-infrared spectra. Chemom. Intell. Lab. Syst. 44, 175\u2212185","author":"Wold S.","year":"1998"},{"key":"tx0256127b00024\/tx0256127b00024_1","volume-title":"Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol. Sci. 65, 135\u2212150","author":"Ruepp S. U.","year":"2002"},{"key":"tx0256127b00025\/tx0256127b00025_1","volume-title":"Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1, 377\u2212396","author":"Tonge R.","year":"2001"},{"key":"tx0256127b00026\/tx0256127b00026_1","volume-title":"NMR lipid-profiles of cells, tissues and body fluids. Magn. Reson. Chem. 29, 594\u2212602","author":"Casu M.","year":"1991"},{"key":"tx0256127b00027\/tx0256127b00027_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1099-1492(200002)13:1<8::AID-NBM602>3.0.CO;2-X","volume":"13","author":"Raffelt K.","year":"2000","journal-title":"NMR Biomed."},{"key":"tx0256127b00028\/tx0256127b00028_1","volume-title":"750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal. Chem. 67, 793\u2212811","author":"Nicholson J. K.","year":"1995"},{"key":"tx0256127b00029\/tx0256127b00029_1","volume":"9","author":"Wong L. T.","year":"1981","journal-title":"Toxicol. Lett."},{"key":"tx0256127b00030\/tx0256127b00030_1","volume-title":"Free radical-induced megamitochondria formation and apoptosis. Free Radical Biol. Med. 26, 396\u2212409","author":"Karbowski M.","year":"1999"},{"key":"tx0256127b00031\/tx0256127b00031_1","volume-title":"Acetaminophen-induced hepatic injury in mice:\u2009 The role of lipid peroxidation and effects of pretreatment with coenzyme Q10 and \u03b1-tocopherol. Free Radical Biol. Med. 19, 169\u2212176","author":"Amimoto T.","year":"1995"},{"key":"tx0256127n00001\/tx0256127n00001_1","volume-title":"alanine aminotransferase","author":"Abbreviations ALT"}],"container-title":["Chemical Research in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/tx0256127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T16:54:52Z","timestamp":1680800092000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/tx0256127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,23]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3,1]]}},"alternative-id":["10.1021\/tx0256127"],"URL":"https:\/\/doi.org\/10.1021\/tx0256127","relation":{},"ISSN":["0893-228X","1520-5010"],"issn-type":[{"value":"0893-228X","type":"print"},{"value":"1520-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,23]]}}}